CME Group Inc.

CME Group Inc., established in Chicago in 1898, operates global marketplaces for the exchange of futures and options contracts. The company provides a wide array of products, encompassing interest rates, equity indexes, foreign exchange, agricultural commodities, energy, metals, and fixed income instruments. Beyond its trading platforms, CME Group delivers essential clearing house functions, which include the clearing, settlement, and guarantee of futures, options, and cleared swaps traded on its exchanges, alongside offering trade processing and risk management solutions. Furthermore, it supplies extensive market data services, covering both real-time and historical information. Its diverse clientele consists of professional traders, financial institutions, individual and institutional investors, corporations, manufacturers, producers, governments, and central banks. The organization changed its name to CME Group Inc. in July 2007, having previously been known as Chicago Mercantile Exchange Holdings Inc.

CME Group Inc. trades as 0HR2.L on LSE. The company is classified in Financial Services / Financial - Data & Stock Exchanges and reports in USD.

The current profile places the business in Financial - Data & Stock Exchanges. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $6.52B of revenue and $4.02B of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

CME Group Inc. can be compared against peers such as The Bank of New York Mellon Corporation, Capital One Financial Corporation, Intercontinental Exchange, Inc., Moody's Corporation, Nasdaq, Inc., The PNC Financial Services Group, Inc..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $92.41B, beta of 0.24, and return on equity of +14.0%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

0HR2.L currently shows total debt of $3.76B and beta of 0.24. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.cmegroup.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.